Common Stock, Shares, Outstanding of Bone Biologics Corp from 31 Oct 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Bone Biologics Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Oct 2010 to 31 Dec 2025.
  • Bone Biologics Corp Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 1,795,260, a 265% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Bone Biologics Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,795,260 +1,302,843 +265% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 1,795,260 -301,480 -14% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 1,685,260 +369,771 +28% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 3,271,042 +2,254,553 +222% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 492,417 -41,821 -7.8% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 2,096,740 -1,037,651 -33% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 1,315,489 -1,818,902 -58% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 1,016,489 -15,686,423 -94% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 534,238 +470,418 +737% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 3,134,391 -7,216,188 -70% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 3,134,391 -7,216,188 -70% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 16,702,912 +6,352,333 +61% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 63,820 -10,286,754 -99% 31 Dec 2022 10-K 21 Feb 2024 2023 FY
Q3 2022 10,350,579 -1,922,457 -16% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 10,350,579 -20,332,011 -66% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 10,350,579 -20,332,011 -66% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 10,350,574 -1,922,462 -16% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 12,273,036 -18,409,554 -60% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 30,682,590 0 0% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 30,682,590 0 0% 31 Mar 2021 10-Q 21 May 2021 2021 Q1
Q4 2020 12,273,036 -18,409,554 -60% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 30,682,590 0 0% 30 Sep 2020 10-Q 15 Apr 2021 2020 Q3
Q2 2020 30,682,590 +616,687 +2.1% 30 Jun 2020 10-Q 15 Apr 2021 2020 Q2
Q1 2020 30,682,590 +2,744,347 +9.8% 31 Mar 2020 10-Q 15 Apr 2021 2020 Q1
Q4 2019 30,682,590 +4,233,709 +16% 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q3 2019 30,682,590 +22,243,405 +264% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 30,065,903 +25,612,163 +575% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 27,938,243 -15,991,087 -36% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 26,448,881 +22,120,801 +511% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 8,439,185 -30,638,137 -78% 30 Sep 2018 10-Q 16 Nov 2018 2018 Q3
Q2 2018 4,453,740 -34,374,867 -89% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 43,929,330 +5,100,723 +13% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 4,328,080 -34,500,527 -89% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 39,077,322 +248,715 +0.64% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 38,828,607 0 0% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 38,828,607 +746,119 +2% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 38,828,607 +6,616,651 +21% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 38,828,607 +7,665,249 +25% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 38,828,607 +9,589,451 +33% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 38,082,488 +13,813,441 +57% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 32,211,956 +7,942,909 +33% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 31,163,358 +13,223,425 +74% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 29,239,156 +24,140,495 +473% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 24,269,047 +19,269,047 +385% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 24,269,047 +13,340,948 +122% 31 Dec 2014 10-K 28 Mar 2016 2015 FY
Q3 2014 17,939,933 +12,939,933 +259% 30 Sep 2014 10-Q 19 Nov 2014 2014 Q3
Q2 2014 5,098,661 +98,661 +2% 30 Jun 2014 8-K 25 Sep 2014
Q1 2014 5,000,000 0 0% 30 Apr 2014 10-Q 23 Jun 2014 2014 Q2
Q4 2013 10,928,099 +5,928,099 +119% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 5,000,000 0 0% 31 Oct 2013 10-Q 15 Sep 2014 2014 Q3
Q2 2013 5,000,000 0 0% 31 Jul 2013 10-Q 11 Sep 2013 2013 Q3
Q1 2013 5,000,000 0 0% 30 Apr 2013 10-Q 14 Jun 2013 2013 Q2
Q4 2012 5,000,000 0 0% 31 Jan 2013 10-Q 18 Mar 2013 2013 Q1
Q3 2012 5,000,000 0 0% 31 Oct 2012 10-K 13 Feb 2014 2013 FY
Q2 2012 5,000,000 0 0% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 5,000,000 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 5,000,000 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 5,000,000 0 0% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 5,000,000 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 5,000,000 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.